Oryzon Genomics 대차 대조표 상태
재무 상태 기준 확인 3/6
Oryzon Genomics has a total shareholder equity of $92.7M and total debt of $19.3M, which brings its debt-to-equity ratio to 20.8%. Its total assets and total liabilities are $118.6M and $25.9M respectively.
주요 정보
20.8%
부채 비율
US$19.27m
부채
| 이자 보상 비율 | n/a |
| 현금 | US$10.79m |
| 주식 | US$92.68m |
| 총 부채 | US$25.88m |
| 총 자산 | US$118.56m |
최근 재무 상태 업데이트
Is Oryzon Genomics (BME:ORY) Using Too Much Debt?
Apr 04
Is Oryzon Genomics (BME:ORY) Weighed On By Its Debt Load?
May 01Oryzon Genomics (BME:ORY) Has Debt But No Earnings; Should You Worry?
Feb 26Recent updates
Growth Investors: Industry Analysts Just Upgraded Their Oryzon Genomics S.A. (BME:ORY) Revenue Forecasts By 54%
Oct 03Oryzon Genomics S.A. (BME:ORY) Screens Well But There Might Be A Catch
Jun 09Is Oryzon Genomics (BME:ORY) Using Too Much Debt?
Apr 04Industry Analysts Just Made A Dazzling Upgrade To Their Oryzon Genomics S.A. (BME:ORY) Revenue Forecasts
Jul 24Is Oryzon Genomics (BME:ORY) Weighed On By Its Debt Load?
May 01Oryzon Genomics (BME:ORY) Has Debt But No Earnings; Should You Worry?
Feb 26If You Had Bought Oryzon Genomics (BME:ORY) Shares A Year Ago You'd Have Earned 18% Returns
Jan 04
재무 상태 분석
단기부채: ORY's short term assets ($14.9M) do not cover its short term liabilities ($15.7M).
장기 부채: ORY's short term assets ($14.9M) exceed its long term liabilities ($10.2M).
부채 대 자본 내역 및 분석
부채 수준: ORY's net debt to equity ratio (9.1%) is considered satisfactory.
부채 감소: ORY's debt to equity ratio has reduced from 33% to 20.8% over the past 5 years.
대차 대조표
현금 런웨이 분석
과거에 평균적으로 적자를 기록했던 기업의 경우, 최소 1년 이상의 현금 유동성을 보유하고 있는지 평가합니다.
안정적인 현금 활주로: ORY has less than a year of cash runway based on its current free cash flow.
예측 현금 활주로: ORY has less than a year of cash runway if free cash flow continues to reduce at historical rates of 6.8% each year